Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 09, 2024 08:00 ET | Source: Curonix LLC

Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System

Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System.
January 18, 2024 08:00 ET | Source: Curonix LLC

Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence

Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
November 01, 2023 09:00 ET | Source: Curonix LLC

Curonix Celebrates 1st Anniversary

POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary. In November 2022, Curonix completed the...
October 10, 2023 09:34 ET | Source: Market.Us

Pain Management Devices Market Set to Soar to USD 9.4 Billion by 2032 || 8.1% CAGR - Opine Market.us Analysts

New York, Oct. 10, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the Pain Management Devices Market size is expected to be worth around USD 9.4 Billion by 2032 from USD 4.4 Billion in 2022,...
June 07, 2023 07:00 ET | Source: Curonix LLC

Independent clinical study shows Curonix’s Freedom® PNS System significantly reduces pain scores and medication usage

POMPANO BEACH, Fla., June 07, 2023 (GLOBE NEWSWIRE) -- Curonix LLC, a medical technology company dedicated to freeing patients from chronic pain, announced the publication of 24 months of data from...
January 11, 2018 08:30 ET | Source: Spotlight Innovation Inc.

Venodol Roll-on, Spotlight Innovation's New Analgesic Product, Now Available at Amazon.com

URBANDALE, IA, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Spotlight Innovation Inc. (OTCQB: STLT), a pharmaceutical company targeting rare, emerging and neglected diseases, today announced that Company...